A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort studyChao Liu, Li Li, Kehan Song, Zhi-Ying Zhan, Yi Yao, Hongyun Gong, Yuan Chen, Qun Wang, Xiaorong Dong, Zhibin Xie, Chun-Quan Ou, Qinyong Hu, Qibin Song
6 September 2020
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNAPedro Barata, Neeraj Agarwal, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Whitley Hatton, Elisa Ledet, Brian Lewis, Jodi Layton, Hani Babiker, Alan Bryce, Rohan Garje, Cy Stein, Lesli Kiedrowski, Philip SaylorSee the full list of authors
11 August 2020
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in ItalyVincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio CelentanoSee the full list of authors
11 August 2020
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunityJia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou
29 July 2020
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatmentErnesto Rossi, Giovanni Schinzari, Giampaolo Tortora
21 July 2020
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19Riyue Bao, Kyle Hernandez, Lei Huang, Jason John Luke
15 July 2020
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapyMadhuri Koti, Alvaro Morales, Charles H Graham, David Robert Siemens
6 July 2020
On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19Thilo Gambichler, Judith Reuther, Christina H Scheel, Jürgen Christian Becker
1 July 2020
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and managementJarushka Naidoo, Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Patrick M Forde, Seema Mehta Steinke, Clare Rock, Douglas B Johnson, Mizuki Nishino, Julie R Brahmer
17 June 2020
COVID-19 and immune checkpoint inhibitors: initial considerationsRyan J Sullivan, Douglas B Johnson, Brian I Rini, Tomas G Neilan, Christine M Lovly, Javid J Moslehi, Kerry L Reynolds
19 May 2020